Belzutifan plus cabozantinib as first-line treatment for patients with advanced clear-cell renal cell carcinoma (LITESPARK-003): an open-label, single-arm, phase 2 study
Titel:
Belzutifan plus cabozantinib as first-line treatment for patients with advanced clear-cell renal cell carcinoma (LITESPARK-003): an open-label, single-arm, phase 2 study
Auteur:
Choueiri, Toni K Merchan, Jaime R Figlin, Robert McDermott, David F Arrowsmith, Edward Michaelson, M Dror Tykodi, Scott S Heath, Elisabeth I Spigel, David R D’Souza, Anishka Kassalow, Laurent Perini, Rodolfo F Vickery, Donna Bauer, Todd M